Alzheimer’s disease (AD), today is the most prevalent form of dementia afflicting more than 50 million people worldwide (Queiroz et al., 2022, Varesi et al., 2022), and with a doubling time of 20 years could easily...read more
–CancerVision designed to democratize fast, affordable cancer analysis and diagnosis with broadened access to complete genomic information– –Company opened San Diego-based corporate...read more
As clinical whole-genome sequencing (WGS) is becoming more of a routine diagnostic test for certain patients with genetic disorders, the Broad Institute has launched a new end-to-end WGS and variant interpretation...read more
enlightenbio provides a conduit between research and related technical and analytical resources. We are dedicated to communicating in the researcher’s language, identifying unmet needs, and understanding product development requirements. Our goals are aligned with the needs of healthcare professionals and organizations to increase productivity and technology development and adaption, and to make sense of the resulting biological data.
Copyright © 2023. enlighenbio LLC. All rights reserved.
Your Header Sidebar area is currently empty. Hurry up and add some widgets.